TVAX Biomedical Names Wayne Carter as President and CEO
Olathe, KS, March 11, 2019 – TVAX Biomedical, a clinical stage development company advancing its proprietary T cell-based immunotherapy for […]
Olathe, KS, March 11, 2019 – TVAX Biomedical, a clinical stage development company advancing its proprietary T cell-based immunotherapy for […]